Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yuan‐Qiu Cheng"'
Autor:
Yan‐Qin Geng, Li‐Na Qiu, Yuan‐Qiu Cheng, Juan‐Juan Li, Yi‐Lin Ma, Cheng‐Cheng Zhao, Ying Cai, Xue‐Bin Zhang, Jieli Chen, Yu‐Chen Pan, Ke‐Rang Wang, Xiu‐Hua Yao, Dong‐Sheng Guo, Jia‐Ling Wu
Publikováno v:
Advanced Science, Vol 11, Iss 24, Pp n/a-n/a (2024)
Abstract Intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) is the primary treatment for ischemic stroke. However, rtPA treatment can substantially increase blood‐brain barrier (BBB) permeability and susceptibility to hem
Externí odkaz:
https://doaj.org/article/9259453f37ac4102890c77fca66fc237
Autor:
Xiao-Min Cao, Yuan-Qiu Cheng, Meng-Meng Chen, Shun-Yu Yao, An-Kang Ying, Xiu-Zhen Wang, Dong-Sheng Guo, Yue Li
Publikováno v:
Nanomaterials, Vol 14, Iss 10, p 864 (2024)
Chemotherapy is one of the most commonly used methods for treating cancer, but its side effects severely limit its application and impair treatment effectiveness. Removing off-target chemotherapy drugs from the serum promptly through adsorption is th
Externí odkaz:
https://doaj.org/article/e3c5c3b2949c4575968457ca5fa44c71
Autor:
Yuan-Qiu Cheng, Yu-Xin Yue, Hong-Mei Cao, Wen-Chao Geng, Lan-Xing Wang, Xin-Yue Hu, Hua-Bin Li, Qiang Bian, Xiang-Lei Kong, Jian-Feng Liu, De-Ling Kong, Dong-Sheng Guo, Yue-Bing Wang
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-21 (2021)
Abstract Background Hypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney injury and chronic kidney disease; however, an effective strategy that can achieve simultaneou
Externí odkaz:
https://doaj.org/article/12e59a16199541c1a614d58b45b0cc4d